iBet uBet web content aggregator. Adding the entire web to your favor.
iBet uBet web content aggregator. Adding the entire web to your favor.



Link to original content: https://doi.org/10.1101/cshperspect.a009407
Leucine-Rich Repeat Kinase 2 for Beginners: Six Key Questions

Leucine-Rich Repeat Kinase 2 for Beginners: Six Key Questions

  1. William T. Dauer1,3
  1. 1Department of Neurology, University of Michigan Medical School, Ann Arbor, Michigan 48109
  2. 2Department of Neuroscience Graduate Program, University of Michigan Medical School, Ann Arbor, Michigan 48109
  3. 3Department of Cell and Developmental Biology, University of Michigan Medical School, Ann Arbor, Michigan 48109
  1. Correspondence: dauer{at}med.umich.edu

Abstract

There has been intense interest in leucine-rich repeat kinase 2 (LRRK2) since 2004, when mutations in the LRRK2 gene were discovered to cause dominantly inherited Parkinson’s disease (PD). This article will address six basic questions about LRRK2 biology as it relates to PD, with particular emphasis on its discovery, current concepts of its physiological and pathological functions, and the strategies being used to discover how LRRK2 dysfunction causes PD.

Also in this Collection

    | Table of Contents

    This Article

    1. Published in Advance January 3, 2012, doi: 10.1101/cshperspect.a009407 Cold Spring Harb Perspect Med 2: Copyright © 2012 Cold Spring Harbor Laboratory Press; all rights reserved
    1. » Abstract
    2. Full Text
    3. Full Text (PDF)
    4. All Versions of this Article:
      1. cshperspect.a009407v1
      2. 2/3/a009407 most recent

    Article Category

    Updates/Comments

    1. Submit updates/comments
    2. No updates/comments published
    3. Alert me when Updates/Comments are published

    Subject Collections

    1. Parkinson's Disease

    Share

    Richard Sever interviews Joan Brugge

    Current Issue

    1. November 2024, 14 (11)
    1. Current Issue